Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemia

No abstract is available for this paper.

• Publication year

  1987

• Venue

  FEBS Letters

• Publication date

  1987-12-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-5793(87)80550-1PMID 2826255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D, chemical, biochemical and clinical update

  1987cited by this paper
• Molecular cloning of complementary DNA encoding the avian receptor for vitamin D.

  1987cited by this paper
• 24- and 26-homo-1,25-dihydroxyvitamin D3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro.

  1987cited by this paper
• Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.

  1987cited by this paper
• Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues.

  1986cited by this paper
• Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.

  1986cited by this paper
• SYNTHETIC STUDIES OF VITAMIN D ANALOGUES. VII. : SYNTHESIS OF 20-OXA-21-NORVITAMIN D3 ANALOGUES

  1986cited by this paper
• Syntheses and differentiating action of vitamin D endoperoxides. Singlet oxygen adducts of vitamin D derivatives in human myeloid leukemia cells (HL-60).

  1985cited by this paper
• Mechanism of the differentiating action of 25-hydroxyvitamin D3 endoperoxides in human myeloid leukemia cells (HL-60).

  1985cited by this paper
• 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.

  1983cited by this paper
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.

  1981cited by this paper

• Vitamin D in the Prevention and Treatment of Inflammatory Skin Diseases

  2025cites this paper
• Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy

  2022cites this paper
• Comparative pharmacokinetics of maxacalcitol in healthy Taiwanese and Japanese subjects

  2020cites this paper
• Enhanced Bioavailability and Anticancer Activity of Vitamin Analogs

  2017cites this paper
• Reminiscences of research on the chemistry and biology of natural sterols in insects, plants and humans

  2013cites this paper
• Ethanol Extract of Tripterygium wilfordii Hook. F. Induces G0/G1 Phase Arrest and Apoptosis in Human Leukemia HL-60 Cells Through c-myc and Mitochondria-Dependent Caspase Signaling Pathways

  2012cites this paper
• differentiation, and induction of WAF1 in myeloid leukemia A new series of vitamin D analogs is highly active for clonal inhibition,

  2011cites this paper
• Danthron inhibits murine WEHI-3 cells in vivo, and enhances macrophage phagocytosis and natural killer cell cytotoxic activity in leukemic mice.

  2011cites this paper
• Novel Vitamin D Analogs for Prostate Cancer Therapy

  2011cites this paper
• Vitamine D analogue-based therapies for psoriasis.

  2010cites this paper
• Dietary Effect of Antrodia Camphorate Extracts on Immune Responses in WEHI-3 Leukemia BALB/c Mice

  2010cites this paper
• Benzyl isothiocyanate inhibits murine WEHI-3 leukemia cells in vitro and promotes phagocytosis in BALB/c mice in vivo.

  2009cites this paper
• A. cantoniensis inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immunoresponses in vivo.

  2009cites this paper
• The potential use of vitamin D analogs in the treatment of cancer

  2009cites this paper
• Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo.

  2009cites this paper
• Catalytic asymmetric synthesis and anticancer effects of the novel non-calcemic analog of vitamin D, 2α-fluoro-19-nor-22-oxa-1α,25-dihydroxyvitamin D3 in metastatic lung carcinoma

  2007cites this paper
• Analysis of in vitro skin permeation of 22-oxacalcitriol from ointments based on a two- or three-layer diffusion model considering diffusivity in a vehicle.

  2007cites this paper
• Carcinoma and Its Synergism with Tamoxifen of Calcitriol , in Athymic Mice Implanted with Human Breast Antitumor Effect of 22-Oxa-calcitriol , a Noncalcemic Analogue

  2006cites this paper
• Analysis of in Vitro Skin Permeation of 22-Oxacalcitriol Having a Complicated Metabolic Pathway

  2006cites this paper
• Effect of 22-Oxa-1 , Thyroid Cancer Cell 25-Dihydroxyvitamin Growth D 3 on Human

  2006cites this paper
• 1 , 25-Dihydroxyvitamin D 3 Receptors and Resistance : Implications in Rickets , Osteomalacia , and Other Conditions

  2006cites this paper
• 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.

  2005cites this paper
• Nephrology Dialysis Transplantation Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients : results of a preliminary study

  2005cites this paper
• CHAPTER 103 – Renal Failure and Secondary Hyperparathyroidism

  2005cites this paper
• CHAPTER 86 – Development of OCT and ED-71

  2005cites this paper
• 1α-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors

  2005cites this paper
• Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues.

  2004cites this paper
• Dose‐response Study of 22‐Oxacalcitriol in Patients with Secondary Hyperparathyroidism

  2004cites this paper
• Efficient modification of steroid 20S-hydroxy functionality for industrial preparation of 1α,25-dihydroxy-22-oxavitamin D3, Maxacalcitol

  2004cites this paper
• Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1α,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues

  2004cites this paper
• In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3.

  2003cites this paper
• Structure–function relationships of vitamin D including ligand recognition by the vitamin D receptor

  2003cites this paper
• Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs.

  2003cites this paper
• Effect of 22-oxacalcitriol on secondary hyperparathyroidism in hemodialysis patients.

  2003cites this paper
• Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs.

  2003cites this paper
• Mechanisms involved in the induced differentiation of leukemia cells.

  2003cites this paper
• Combination of 22-oxa-1,25-dihydroxyvitamin D3, a vitamin D3 derivative, with vitamin K2 (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells

  2002cites this paper
• Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failure.

  2002cites this paper
• [A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone secretion and calcemic action].

  2002cites this paper
• Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.

  2002cites this paper
• A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action.

  2002cites this paper
• A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats.

  2002cites this paper
• Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism.

  2002cites this paper
• 22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats.

  2002cites this paper
• Chapter 3 – Osteoclast Biology

  2001cites this paper
• Vitamin D: Biology, Actions, and Clinical Implications

  2001cites this paper
• History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2beta-(3-hydroxypropoxy)calcitriol (ED-71).

  2001cites this paper
• Synthesis and evaluation of A-ring diastereomers of 1alpha,25-dihydroxy-22-oxavitamin D3 (OCT).

  2001cites this paper
• The contribution of mesangial cell proliferation to progressive glomerular injury.

  2001cites this paper
• Vitamin DBiology, Action, and Clinical Implications

  2001cites this paper
• Metabolism of a 20-methyl substituted series of vitamin D analogs by cultured human cells: apparent reduction of 23-hydroxylation of the side chain by the 20-methyl group.

  2001cites this paper
• Ligand recognition by the vitamin D receptor.

  2001cites this paper
• The contribution of mesangial cell proliferation to progressive glomerular injury

  2001cites this paper
• Structure-function analysis of vitamin D and VDR model.

  2000cites this paper
• 1&agr;,25-Dihydroxyvitamin D3 and Its Potent Synthetic Analogs Downregulate Tissue Factor and Upregulate Thrombomodulin Expression in Monocytic Cells, Counteracting the Effects of Tumor Necrosis Factor and Oxidized LDL

  2000cites this paper
• Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo‐controlled, double‐blind, dose‐finding study with active comparator

  1999cites this paper
• The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes

  1999cites this paper
• New analogs of vitamin D3.

  1999cites this paper
• 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.

  1999cites this paper
• Effect of 22-oxa-1,25-dihydroxyvitamin D3 on human thyroid cancer cell growth.

  1999cites this paper
• Vitamin D Analogs: Perspectives for Treatment

  1999cites this paper
• A Vitamin D Analog Regulates Mesangial Cell Smooth Muscle Phenotypes in a Transforming Growth Factor-β Type II Receptor-mediated Manner*

  1999cites this paper
• Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D.

  1999cites this paper
• 22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis.

  1999cites this paper
• A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.

  1998cites this paper
• A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.

  1998cites this paper
• The Biological Activity of Nonsteroidal Vitamin D Hormone Analogs Lacking Both the C‐ and D‐Rings

  1998cites this paper
• Attenuated up‐regulation of vitamin D‐dependent calcium‐binding proteins by 22‐oxa‐1,25‐dihydroxyvitamin D3 in uremic rats: A possible mechanism for less‐calcemic action

  1998cites this paper
• The noncalcemic vitamin D analogs EB1089 and 22-oxacalcitriol suppress serum-induced parathyroid hormone-related peptide gene expression in a lung cancer cell line.

  1998cites this paper
• In Vivo Dose-related Receptor Binding of the Vitamin D Analogue [3H]-1,25-dihydroxy-22-oxavitamin D3 (OCT) in Rat Parathyroid, Kidney Distal and Proximal Tubules, Duodenum, and Skin, Studied by Quantitative Receptor Autoradiography

  1998cites this paper
• Differential time course of induction of 1alpha,25-dihydroxyvitamin D3-24-hydroxylase mRNA expression in rats by 1alpha,25-dihydroxyvitamin D3 and its analogs.

  1998cites this paper
• In vivo metabolism off the vitamin D analog, 22-oxacalcitriol: Evidence for side-chain truncation and 17-hydroxylation

  1998cites this paper
• Conformation-function relationship of vitamin D: conformational analysis predicts potential side-chain structure.

  1998cites this paper
• Determination of 22-oxacalcitriol, a new analog of 1alpha,25-dihydroxyvitamin D3, in human serum by liquid chromatography-mass spectrometry.

  1998cites this paper
• Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines.

  1997cites this paper
• Metabolism of the vitamin D analog EB1089 by cultured human cells: redirection of hydroxylation site to distal carbons of the side-chain.

  1997cites this paper
• Practical Formation of ?-Keto or ?-Hydroxy Ether Linkage from Alcohol

  1997cites this paper
• 1,25-Dihydroxyvitamin D3 and a new analogue, 22-oxacalcitriol, modulate proliferation and interleukin-8 secretion of normal human keratinocytes.

  1997cites this paper
• Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.

  1997cites this paper
• Structural organization of the human vitamin D receptor chromosomal gene and its promoter.

  1997cites this paper
• Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines

  1997cites this paper
• The noncalcemic vitamin D analogues EB1089 and 22-oxacalcitriol interact with the vitamin D receptor and suppress parathyroid hormone-related peptide gene expression.

  1997cites this paper
• DIFFERENTIAL TIME COURSE OF INDUCTION OF 1α,25-DIHYDROXYVITAMIN D3-24-HYDROXYLASE mRNA EXPRESSION IN RATS BY 1α,25-DIHYDROXYVITAMIN D3 AND ITS ANALOGS

  1997cites this paper
• An Efficient Stereoselective Synthesis of 1α,24(R)- Dihydroxyvitamin D3 by the Dienyne Route.

  1997cites this paper
• Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells.

  1996cites this paper
• Synthetic studies of vitamin D analogs. XXII. Synthesis and antiproliferation activity of putative metabolites of 1 alpha, 25-dihydroxy-22-oxavitamin D3.

  1996cites this paper
• Treatment of the myelodysplastic syndromes: an updated Japanese experience.

  1996cites this paper
• Conformationally restricted analogs of 1 alpha, 25-dihydroxyvitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor.

  1996cites this paper
• Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines.

  1996cites this paper
• In Vitro Metabolism of the Vitamin D Analog, 22-Oxacalcitriol, Using Cultured Osteosarcoma, Hepatoma, and Keratinocyte Cell Lines (*)

  1996cites this paper
• Induction of Differentiation and Production of Cytokines of HL-60 Cells by 22-Oxa-1α, 25-Dihydroxyvitamin D 3

  1996cites this paper
• A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.

  1996cites this paper
• Radioimmunoassay method for the determination of 22-oxacalcitriol, a novel analog of 1 alpha,25-dihydroxyvitamin D3 having valuable clinical potency, in rat and human plasma.

  1995cites this paper
• Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.

  1995cites this paper
• Synthesis of 20-fluorovitamin D analogues

  1995cites this paper
• 22-Oxacalcitriol does not interfere with parathyroid hormone-induced phosphaturia or cyclic-AMP excretion.

  1995cites this paper
• Synthesis of tritiated 1α,25-dihydroxy-22-oxavitamin D3

  1995cites this paper
• Inhibition of Chemical Carcinogenesis

  1995cites this paper
• Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.

  1995cites this paper
• Structure-function relationships in the vitamin D endocrine system.

  1995cites this paper